Clinical Trial: A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06891066) titled 'A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)' on March 17.

Brief Summary: Researchers are trying to find better treatments for people with HIV-1. In this clinical study, they want to see how well a new treatment called ISL+ULO, taken once a week, works compared to an existing treatment called BIC/FTC/TAF, which is taken every day. They will check how many people still have a high level of the virus in their blood after 24 weeks. The researchers also want to understand if the new treatment, MK-8591B, is safe and h...